PDB26 ESTIMATED RENAL AND CARDIOVASCULAR OUTCOMES AND COST OFFSETS IN PATIENTS WITH TYPE 2 DIABETES (T2D) AND DIABETIC NEPHROPATHY (DKD) TREATED WITH CANAGLIFLOZIN
2019 ◽
Vol 10
(4)
◽
pp. 1041-1049
◽
2003 ◽
Vol 138
(7)
◽
pp. 542
◽
2014 ◽
Vol 64
(5)
◽
pp. 714-722
◽
Keyword(s):
Keyword(s):
Keyword(s):